Diabetes Therapeutics Market 2026 expanding toward $278.96 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Diabetes Therapeutics Market During 2026–2030?

The diabetes therapeutics market has expanded swiftly in recent years. It is anticipated to increase from $170.06 billion in 2025 to $188.19 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.7%. The expansion observed historically can be linked to the limited access to advanced therapeutic options, a reliance on conventional oral anti-diabetic drugs, inadequate awareness of preventive healthcare, restricted distribution channels, and the increasing burden of type 2 diabetes.

The diabetes therapeutics market size is projected to undergo significant expansion in the upcoming years. It is expected to reach $278.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth can be attributed to several factors including the development of novel insulin analogs, the increasing availability of combination therapies, the widespread adoption of digital diabetes management tools, enhancements in healthcare infrastructure for diabetes care, and the integration of telemedicine and remote monitoring services. Prominent trends observed during this forecast period include the rising global prevalence of diabetes, the increasing uptake of glp-1 receptor agonists and sglt-2 inhibitors, the broadening reach of online and retail pharmacies, an intensified focus on personalized diabetes management, and improved awareness regarding preventive care and early diagnosis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25749&type=smp

Which Economic Or Industry Drivers Are Impacting The Diabetes Therapeutics Market?

The growing occurrence of obesity is projected to boost the expansion of the diabetes therapeutics market in the future. Obesity, characterized by an unhealthy excess of fat, poses a significant health hazard and stands as a primary risk factor for type 2 diabetes. The heightened incidence of obesity stems from a greater intake of high-calorie foods, as more individuals consume processed and fast foods rich in sugar and fat, coupled with reduced physical activity, resulting in substantial weight gain. Diabetes therapeutics aid in the management of obesity by enhancing blood sugar regulation and assisting with weight loss, utilizing medications like GLP-1 receptor agonists that diminish appetite and decelerate digestion, thereby improving the overall metabolic health of obese individuals. For example, a report released in May 2024 by the Office for Health Improvement and Disparities, a UK-based government department, indicated that from 2022 to 2023, roughly 64% of adults aged 18 and above were categorized as overweight or obese, representing an increase from the 63.8% recorded in the preceding year. Consequently, the rising occurrence of obesity is fueling the growth of the diabetes therapeutics market.

How Are The Various Segments Of The Diabetes Therapeutics Market Categorized?

The diabetes therapeutics market covered in this report is segmented –

1) By Drug: Oral Anti-Diabetic Drugs, Insulin, Non-Insulin Injectable Drug, Combination Drug

2) By Type: Diabetes 1, Diabetes 2

3) By Route Of Administration: Oral, Subcutaneous, Intravenous

4) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies

5) By Application: Preventive, Treatment Or Care

Subsegments:

1) By Oral Anti-Diabetic Drugs: Biguanides, Sulfonylureas, DPP-4 Inhibitors, SGLT-2 Inhibitors, Thiazolidinediones, Meglitinides, Alpha-Glucosidase Inhibitors

2) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Premixed Insulin

3) By Non-Insulin Injectable Drug: GLP-1 Receptor Agonists, Amylin Analogs

4) By Combination Drug: Oral Combination Therapies, Oral and Injectable Combination Therapies

What Trends Are Affecting The Expansion Of The Diabetes Therapeutics Market?

Leading companies within the diabetes therapeutics market are prioritizing the development of innovative approaches, such as cognitive behavioral therapy (CBT), to enhance customized diabetes care and improve glycemic control for individuals with type 2 diabetes. Cognitive behavioral therapy (CBT) is defined as a structured, empirically supported psychological intervention that assists people in recognizing and altering detrimental thought processes and actions. An illustrative example occurred in October 2023, when Better Therapeutics Inc., a digital therapeutics company based in the US, introduced AspyreRx, a digital application designed for diabetes therapy. AspyreRx, which secured FDA authorization for addressing type 2 diabetes, delivers personalized cognitive behavioral therapy (CBT) to patients 18 and older to encourage behavioral modifications that enhance diabetes management. Previously known as BT-001, AspyreRx showed statistically and clinically notable, lasting decreases in A1c when compared to standard care, alongside improvements in blood pressure, weight, mood, and overall quality of life during a randomized controlled trial.

Which Major Firms Influence Developments In The Diabetes Therapeutics Market?

Major companies operating in the diabetes therapeutics market are Pfizer Inc., Merck & Co Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Biocon Biologics Limited, MannKind Corporation, Lexicon Pharmaceuticals Inc., Adocia S.A., Oramed Pharmaceuticals Inc.

Read the full diabetes therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/diabetes-therapeutics-global-market-report

What Are The Top-Performing Regions Within The Diabetes Therapeutics Market?

North America was the largest region in the diabetes therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Diabetes Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25749&type=smp

Browse Through More Reports Similar to the Global Diabetes Therapeutics Market 2026, By The Business Research Company

Antidiabetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

Non Insulin Therapies For Diabetes Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-insulin-therapies-for-diabetes-global-market-report

Antidiabetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795